Children’s Medical Research Institute (CMRI) pioneered microsurgery, immunisations against lethal childhood illnesses, and care for premature babies, all of which has improved the lives of countless Australian children.
The work at CMRI is made possible by a network of devoted community supporters and Jeans for Genes®, the iconic fundraising campaign established in 1994 to fund revolutionary research that helps diagnose, understand, and find cures or treatments for conditions affecting kids.
Today, CMRI is an independent institute and the site of world-leading research in the areas of cancer, neurobiology, embryology, proteogenomics and gene therapy. CMRI is affiliated with the University of Sydney and is a founding partner of Paediatrio and the Westmead Research Hub.
CMRI collaborates with scientists all over the world to push research forward. It also provides important resources for scientists in Australia. It operates CellBank Australia™, the only national repository of cell cultures in Australia, necessary for many fields of medical science; as well as advanced gene therapy and gene engineering facilities--creating treatments of the future. In addition, CMRI houses the ACRF Cancer Centre, which includes the ACRF Centre for Kinomics, ACRF Telomere Analysis Centre and ACRF ProCan®, whose combined efforts are to understand, improve diagnosis, survivability and discover new treatments for all types of cancer.
At Argenta we've been dedicated to animal health from day one. Since 2006, we've been a trusted partner to clients who need our expertise, partnership and no-challenge-too-tough attitude to bringing innovative new animal health products to market.
Because we are the only global CRO and CMO specializing in animal health, we are uniquely able to offer clients of all sizes a comprehensive product development solution from Molecule to Market, at any scale.
The day-to-day ethos that drives our company forward is a mission focused on global partnerships, a Molecule to Market approach, and of course, innovation.
At the core of our business and our organisation is collaboration — among our global team and with our customers. Working together, we continually challenge ourselves and each other to continue to innovate to develop the best animal health technologies and products possible.
From animal scientists to veterinarians to engineers and other industry experts, our 450+ strong global team is a passionate and diverse group united in their commitment to healthy animals.
We operate from Research & Development locations in New Zealand and the US and (EMA and FDA) GMP approved Manufacturing sites in New Zealand, the United Kingdom (Scotland) and the United States (Fort Dodge, Iowa).
Our company was founded in New Zealand by Doug Cleverly, a scientist who naturally felt more at home in the lab solving problems than in the boardroom. Doug imbued the company with the spirit of Kiwi ingenuity and a global perspective. He saw a need in the market for an animal health company that could provide the highest quality services to customers of all sizes, all over the world. To this day, we are still dedicated to animal health and our founder's legacy of problem solving and inventiveness lives on within the organisation.
Avance Clinical is the largest full-service Australian CRO specializing in delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs.
Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, has been providing CRO services in the region for the past 24 years.
The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.
Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.
With experience across more than 105 indications the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.
Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.
As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of Avance Clinical’s trusted technology partners.
Visit http://www.avancecro.com for more information.
Excellence in Business Award 2021
Frost & Sullivan Asia-Pacific CRO Market Leadership Award 2020
Datapharm is Australia’s original independent full-service Contract Research Organisation (CRO), est. 1987, providing clinical trial management, design, site set-up, monitoring, statistical services, data management (including eCRFs), medical writing, pharmacovigilance and auditing.
Datapharm has earned an enviable reputation for quality, following involvement in hundreds of clinical trials in over 35 therapeutic areas, Phases I (including first-in-human) to IV, for Big Pharma, Biotech, Medical Device companies and Non-profit organisations.
Datapharm works to ICH GCP and international regulatory authority standards with an overlay of excellent project management to achieve project milestones.
Datapharm offers services internationally through the global CRO consortium DAI-SYS.
Novotech is internationally recognized as a leading regional full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety solutions, central lab services, report write-up to ICH requirements, project and vendor management. Novotech’s strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.